Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Quintiles adopts methods ‘to cut red tape’

Quintiles adopts methods ‘to cut red tape’

16th January 2009

Quintiles has said it has adopted contractual methods, in order to ‘cut red tape’.

The company noted they included common contract language and standardised clauses, which have been developed by CEO Roundtable on Cancer.

As a result, Quintiles said the adoption of the methods would “significantly reduce contract negotiation time”, which averages at 172 days, but can take one year.

Oren Cohen, the company’s chief medical and scientific officer – and member of the CEO Roundtable Life Sciences Consortium – commented the time it takes to get final clinical trial agreement can be a cause of delays in experimental drug development.

He added: “We are hopeful that streamlining the process to begin a cancer trial will shorten the time it takes to get critically-needed therapies to the patients who need them.”

Last month, the company said it had acquired Target Molecular Diagnostics.

Speaking at the time, Dr King Jolly, senior vice-president of drug development partnerships for Quintiles’ managed partnership group NovaQuest, stated he hoped the deal with the oncology-focused diagnostic laboratory would “help customers develop novel, targeted cancer therapies”.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.